Japanese artificial intelligence system diagnoses colorectal cancer in 0.3 seconds

Share This Post

Japanese researchers have developed an artificial intelligence system that extends an endoscope with a magnification of 500 times into the patient ‘s intestine. The artificial intelligence system can identify whether there is malignant change in the large intestine polyp in the endoscope within 0.3 seconds, according to real-time judgment results The doctor can decide whether to operate in real time.

Compared with the past, it takes a week to make a diagnosis, and now the system can immediately determine whether to remove it, which greatly improves the efficiency of diagnosis and treatment. During the development of this system, more than 60,000 tumor cell pictures were used to build a database. These pictures came from more than 3,000 patients with colorectal cancer diagnosed in 5 hospitals in Japan. By analyzing and deep learning the tumor images in the image database, the system has learned the automatic recognition function of cancer. Not only improve the diagnosis efficiency, but also improve the accuracy.

In Japan, colorectal cancer is the second most malignant tumor after death from lung cancer. Early detection is the key to improving the level of treatment. This artificial intelligence achievement in Japan can detect the presence of cancer in large intestine polyps in less than a second. At present, this artificial intelligence colorectal cancer diagnostic system has been clinically tested in 6 hospitals in Japan, and is expected to obtain the license from the relevant Japanese pharmaceutical regulatory authorities in 2018. 

Subscribe To Our Newsletter

Get updates and never miss a blog from Cancerfax

More To Explore

Gamma Delta T Cell therapy in Malaysia
CAR T-Cell therapy

Gamma Delta T Cell Therapy in Malaysia: A Revolution in Cancer Treatment

Gamma Delta T Cell therapy is revolutionizing cancer treatment by harnessing the immune system’s power. This innovative approach is gaining momentum in Malaysia, a rising medical hub in Southeast Asia. With cutting-edge facilities, cost-effective treatments, and strong government support, Malaysia is advancing this therapy to offer hope to cancer patients. By focusing on research and international collaborations, the country is poised to lead the region in next-generation cancer care.

Gamma Delta T Cell therapy in Sinagpore
CAR T-Cell therapy

Gamma Delta T Cell Therapy in Singapore: A Revolutionary Approach for Late-Stage Cancer Treatment

Gamma Delta (GD) T Cell therapy is revolutionizing stage 4 cancer treatment, offering hope to metastatic cancer patients. At Singapore’s National University Hospital (NUH), the ANGELICA trials harness the unique tumor-targeting abilities of GD T cells. This cutting-edge therapy minimizes side effects, enhances survival rates, and improves quality of life. As a global leader in medical innovation, Singapore positions itself as a premier destination for advanced cancer therapies like GD T Cell therapy.

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

Start chat
We Are Online! Chat With Us!
Scan the code
Hello,

Welcome to CancerFax !

CancerFax is a pioneering platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies like CAR T-Cell therapy, Gene therapy, TIL therapy, and clinical trials worldwide.

Let us know what we can do for you.

1) CAR T-Cell therapy
2) Gene therapy
3) Gamma-Delta T Cell therapy
4) TIL therapy
5) NK Cell therapy